Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies
Genes · 2023
DOI: 10.3390/genes14030715 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Zuzana Holesova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Geneton s.r.o., 84104 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund.
Abstract (Originalsprache)
Telomere dynamics play a crucial role in the maintenance of chromosome integrity; changes in telomere length may thus contribute to the development of various diseases including cancer. Understanding the role of telomeric DNA in carcinogenesis and detecting the presence of cell-free telomeric DNA (cf-telDNA) in body fluids offer a potential biomarker for novel cancer screening and diagnostic strategies. Liquid biopsy is becoming increasingly popular due to its undeniable benefits over conventional invasive methods. However, the organization and function of cf-telDNA in the extracellular milieu are understudied. This paper provides a review based on 3,398,017 cancer patients, patients with other conditions, and control individuals with the aim to shed more light on the inconsistent nature of telomere lengthening/shortening in oncological contexts. To gain a better understanding of biological factors (e.g., telomerase activation, alternative lengthening of telomeres) affecting telomere homeostasis across different types of cancer, we summarize mechanisms responsible for telomere length maintenance. In conclusion, we compare tissue- and liquid biopsy-based approaches in cancer assessment and provide a brief outlook on the methodology used for telomere length evaluation, highlighting the advances of state-of-the-art approaches in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geneton s.r.o., 84104 Bratislava, Slovakia.
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia.
- Comenius University Science Park, Comenius University, 84104 Bratislava, Slovakia.
- Slovak Centre of Scientific and Technical Information, 81104 Bratislava, Slovakia.
- Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, 84205 Bratislava, Slovakia.
- Medirex Group Academy, n.o., 94905 Nitra, Slovakia.
ORCID-Profile: Rami Saade, Jaroslav Budis, Juraj Gazdarica
Förderung
- European Regional Development Fund
Zitieren
APA
Holesova, Z., Krasnicanova, L., Saade, R., Pös, O., Budis, J., Gazdarica, J., Repiska, V., & Szemes, T. (2023). Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies. Genes. https://doi.org/10.3390/genes14030715
Vancouver
Holesova Z, Krasnicanova L, Saade R, Pös O, Budis J, Gazdarica J, et al. Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies. Genes. 2023. doi:10.3390/genes14030715
BibTeX
@article{Holesova2023,
author = {Holesova, Zuzana and Krasnicanova, Lucia and Saade, Rami and Pös, Ondrej and Budis, Jaroslav and Gazdarica, Juraj and Repiska, Vanda and Szemes, Tomas},
title = {Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14030715}
}
EUVIMED